1,050 results on '"Lilja H"'
Search Results
152. Beta-Microseminoprotein in Serum Correlates With the Levels in Seminal Plasma of Young, Healthy Males
153. Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence
154. Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population
155. 929 CORRELATION OF POSTOPERATIVE HEMOGLOBIN LEVELS AND BLOOD LOSS AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY
156. 911 PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY USING A TISSUE MICROARRAY OF 947 PRIMARY PROSTATE CANCERS AND IMMUNOHISTOCHEMICAL DETECTION OF CYSTEINE-RICH SECRETORY PROTEIN 3 (CRISP-3) AND BETA-MICROSEMINOPROTEIN (MSP)
157. Preliminary sublimation studies
158. Regulation of cystatin C activity by serine proteinases
159. MP-10.21
160. 612Lower prostate specific antigen (PSA) levels in seminal plasma in young men with the homozygous A/A genotype in the androgen response element 1 of the PSA gene
161. 121A single measurement of prostate-specific antigen and human kallikrein 2 could predict tumour aggressiveness up to 20 years before prostate cancer diagnosis
162. 123PSA and the future risk of prostate cancer
163. 1029 Evaluation of free psa sub forms and human glandular kallikrein 2 levels as predictors of biochemical recurrence after radical prostatectomy for localized prostate cancer
164. Defining a new threshold for PSA outcomes in untreated prostate cancer
165. 128 Serum concentrations of human glandular kallikrein 2 (HK2) but not free PSA, total PSA or %FPSA permit discrimination of pathologically organ-confined (OC) from non-organ confined (NOC), non-palpable (clinical stage T1C) prostate cancer
166. 358 Vascular endothelial growth factor autocrine loop in prostate cancer cells generated after prolonged treatment with interleukin-6
167. Prostate-Specific Antigen-Activated Thapsigargin Prodrug as Targeted Therapy for Prostate Cancer
168. Androgen receptor polymorphism as determinator of variation in prostatic activity in adolecense
169. Antithrombin expression in the malignant and benign prostate: An anti-angiogenetic factor and inhibitor of PSA and HK2
170. Blood levels of free-PSA, but not complexed-PSA, correlate to levels of PSA in seminal fluid contributed by the prostate gland in healthy young men
171. Free PSA is eliminated by glomerular filtration
172. Neutral endopeptidase (EC 3.4.24.11) is differentially distributed in the normal and the pathologically altered prostate
173. Correlation of molecular PSA subfractions with volume of benign and malignant prostate cancer tissue
174. Free PSA fraction, nicked PSA, discriminates prostate cancer from non-cancerous condition
175. Sensitive two-site immunoassays for measurement of the free and total forms of human glandular kallikrein 2 (hK2)
176. Role of hK2, Free PSA, and Complexed PSA Measurements in the Very Early Detection of Prostate Cancer
177. Would prostate cancer detected by screening withprostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden
178. A Genome-wide scan for low HDL-Cholesterol in genetically isolated finnish families with premature coronary heart disease
179. Isolated low HDL-cholesterol syndrome in finnish families with premature CAD
180. Localization of protein gene product 9.5 immunoreactivity in derivatives of the human Wolffian duct and in prostate cancer
181. Localization of protein gene product 9.5 immunoreactivity in derivatives of the human Wolffian duct and in prostate cancer
182. Characterization of Epitope Structure for 53 Monoclonal Antibodies against Prostate-Specific Antigen
183. Reactivity of Anti-PSA Monoclonal Antibodies with Recombinant Human Kallikrein-2
184. Summary Report of the TD-3 Workshop: Characterization of 83 Antibodies against Prostate-Specific Antigen
185. Response of Cultured Fetal and Adult Rat Hepatocytes to Growth Factors and Cyclosporine
186. CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN
187. Prostate-specific antigen: molecular forms and the human kallikrein gene family
188. Intrauterine growth curves based on ultrasonically estimated foetal weights
189. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum
190. Repeat abortion: a comparative study
191. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex
192. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
193. Production of Recombinant PSA and HK2 and Analysis of Their Immunological Cross-Reactivity
194. The gene encoding vitamin K-dependent anticoagulant protein C is expressed in human male reproductive tissues.
195. Biochemistry of prostate specific antigen, PSA
196. The use of contraceptive methods among women seeking a legal abortion
197. Reply by the authors
198. Expression of Prostate Specific Antigen on the Surface of a Filamentous Phage
199. Evaluation of stated motives for legal abortion
200. Power spectrum analysis of the fetal heart rate during noradrenaline infusion and acute hypoxemia in the chronic fetal lamb preparation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.